Colleen Hoover, the celebrated author behind major Hollywood hits, has publicly revealed she is undergoing treatment for cancer. The writer shared the deeply personal health update with her 1.9 million Instagram followers on Monday.
A Candid Health Update from Hospital
In a mirror selfie taken in a hospital gown, Hoover grimaced as she marked a significant milestone in her treatment. The author disclosed she was experiencing her "second to last day of radiation." She praised her medical team at Texas Oncology, writing, "Hope you never need them, but highly recommend them."
Hoover explained that the cancer had initially been removed via surgery and was now being treated with follow-up radiation. She admitted the situation felt "huge and scary" and had forced her to miss major career events, including the premiere of the film adaptation of her other novel, Regretting You, in October 2025.
Career Success Overshadowed by Health and Legal Struggles
The author's revelation comes during a period of immense professional success, with both It Ends With Us and Regretting You becoming blockbuster films. However, the production of It Ends With Us was marred by significant behind-the-scenes legal conflict.
Lead actress Blake Lively filed a legal complaint accusing director Justin Baldoni and his production company of sexual harassment and fostering a hostile work environment. Baldoni denied all allegations and subsequently filed a staggering $400 million countersuit against Lively and her husband, Ryan Reynolds, for defamation and allegedly orchestrating a smear campaign. A judge later dismissed much of this countersuit.
A Message to Fans and Followers
In a separate Facebook post, Hoover opened up about her decision to keep her diagnosis private until she understood the prognosis. She ended her message with crucial advice for her fans, urging them to "listen to your body" and seek medical advice if anything feels "off." Her candid disclosure has sparked an outpouring of support from readers and the literary community worldwide.